|
1.
|
Takayama T, Makuuchi M, Hirohashi S, et
al: Early hepatocellular carcinoma as an entity with a high rate of
surgical cure. Hepatology. 28:1241–1246. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Zhang BH, Yang BH and Tang ZY: Randomized
controlled trial of screening for hepatocellular carcinoma. J
Cancer Res Clin Oncol. 130:417–422. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Portolani N, Coniglio A, Ghidoni S, et al:
Early and late recurrence after liver resection for hepatocellular
carcinoma: prognostic and therapeutic implications. Ann Surg.
243:229–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Yang Y, Nagano H, Ota H, et al: Patterns
and clinicopathologic features of extrahepatic recurrence of
hepatocellular carcinoma after curative resection. Surgery.
141:196–202. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Burroughs A, Hochhauser D and Meyer T:
Systemic treatment and liver transplantation for hepatocellular
carcinoma: two ends of the therapeutic spectrum. Lancet Oncol.
5:409–418. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Nowak AK, Chow PK and Findlay M: Systemic
therapy for advanced hepatocellular carcinoma: a review. Eur J
Cancer. 40:1474–1484. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Llovet JM, Ricci S, Mazzaferro V, et al:
Sorafenib in advanced hepatocellular carcinoma. N Engl J Med.
359:378–390. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Cheng AL, Kang YK, Chen Z, et al: Efficacy
and safety of sorafenib in patients in the Asia-Pacific region with
advanced hepatocellular carcinoma: a phase III randomised,
double-blind, placebo-controlled trial. Lancet Oncol. 10:25–34.
2009. View Article : Google Scholar
|
|
9.
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: an update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Kudo M, Izumi N, Kokudo N, et al HCC
Expert Panel of Japan Society of Hepatology: Management of
hepatocellular carcinoma in Japan: Consensus-Based Clinical
Practice Guidelines proposed by the Japan Society of Hepatology
(JSH) 2010 updated version. Dig Dis. 29:339–364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Sasaki A, Kai S, Endo Y, et al: Hepatitis
B virus infection predicts extrahepatic metastasis after hepatic
resection in patients with large hepatocellular carcinoma. Ann Surg
Oncol. 14:3181–3187. 2007. View Article : Google Scholar
|
|
12.
|
Uka K, Aikata H, Takaki S, et al: Clinical
features and prognosis of patients with extrahepatic metastases
from hepatocellular carcinoma. World J Gastroenterol. 13:414–420.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Uchino K, Tateishi R, Shiina S, et al:
Hepatocellular carcinoma with extrahepatic metastasis: clinical
features and prognostic factors. Cancer. 117:4475–4483. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Jun L, Zhenlin Y, Renyan G, et al:
Independent factors and predictive score for extrahepatic
metastasis of hepatocellular carcinoma following curative
hepatectomy. Oncologist. 17:963–969. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pawlik TM, Esnaola NF and Vauthey JN:
Surgical treatment of hepatocellular carcinoma: similar long-term
results despite geographic variations. Liver Transpl. 10(Suppl 1):
S74–S80. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Shim JH, Park JW, Kim JH, et al:
Association between increment of serum VEGF level and prognosis
after transcatheter arterial chemoembolization in hepatocellular
carcinoma patients. Cancer Sci. 99:2037–2044. 2008.
|
|
17.
|
Paez-Ribes M, Allen E, Hudock J, et al:
Antiangiogenic therapy elicits malignant progression of tumors to
increased local invasion and distant metastasis. Cancer Cell.
15:220–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kong J, Kong J, Pan B, et al: Insufficient
radiofrequency ablation promotes angiogenesis of residual
hepatocellular carcinoma via HIF-1alpha/VEGFA. PLoS One.
7:e372662012. View Article : Google Scholar
|
|
19.
|
Katyal S, Oliver JH III, Peterson MS,
Ferris JV, Carr BS and Baron RL: Extrahepatic metastases of
hepatocellular carcinoma. Radiology. 216:698–703. 2000. View Article : Google Scholar
|
|
20.
|
Yoo DJ, Kim KM, Jin YJ, et al: Clinical
outcome of 251 patients with extrahepatic metastasis at initial
diagnosis of hepatocellular carcinoma: does transarterial
chemoembolization improve survival in these patients? J
Gastroenterol Hepatol. 26:145–154. 2011. View Article : Google Scholar
|
|
21.
|
Natsuizaka M, Omura T, Akaike T, et al:
Clinical features of hepatocellular carcinoma with extrahepatic
metastases. J Gastroenterol Hepatol. 20:1781–1787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ochiai T, Ikoma H, Okamoto K, Kokuba Y,
Sonoyama T and Otsuji E: Clinicopathologic features and risk
factors for extrahepatic recurrences of hepatocellular carcinoma
after curative resection. World J Surg. 36:136–143. 2012.
View Article : Google Scholar
|
|
23.
|
Pinter M, Hucke F, Graziadei I, et al:
Advanced-stage hepatocellular carcinoma: transarterial
chemoembolization versus sorafenib. Radiology. 263:590–599. 2012.
View Article : Google Scholar
|
|
24.
|
Pinter M, Sieghart W, Graziadei I, et al:
Sorafenib in unresectable hepatocellular carcinoma from mild to
advanced stage liver cirrhosis. Oncologist. 14:70–76. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Niizeki T, Sumie S, Torimura T, et al:
Serum vascular endothelial growth factor as a predictor of response
and survival in patients with advanced hepatocellular carcinoma
undergoing hepatic arterial infusion chemotherapy. J Gastroenterol.
47:686–695. 2012. View Article : Google Scholar
|
|
26.
|
Ding PR, An X, Zhang RX, et al: Elevated
preoperative neutrophil to lymphocyte ratio predicts risk of
recurrence following curative resection for stage IIA colon cancer.
Int J Colorectal Dis. 25:1427–1433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Jung MR, Park YK, Jeong O, et al: Elevated
preoperative neutrophil to lymphocyte ratio predicts poor survival
following resection in late stage gastric cancer. J Surg Oncol.
104:504–510. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Stotz M, Gerger A, Eisner F, et al:
Increased neutrophillymphocyte ratio is a poor prognostic factor in
patients with primary operable and inoperable pancreatic cancer. Br
J Cancer. 109:416–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Gomez D, Farid S, Malik HZ, et al:
Preoperative neutrophil-to-lymphocyte ratio as a prognostic
predictor after curative resection for hepatocellular carcinoma.
World J Surg. 32:1757–1762. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Halazun KJ, Hardy MA, Rana AA, et al:
Negative impact of neutrophil-lymphocyte ratio on outcome after
liver transplantation for hepatocellular carcinoma. Ann Surg.
250:141–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Huang ZL, Luo J, Chen MS, Li JQ and Shi M:
Blood neutrophil-to-lymphocyte ratio predicts survival in patients
with unresectable hepatocellular carcinoma undergoing transarterial
chemoembolization. J Vasc Interv Radiol. 22:702–709. 2011.
View Article : Google Scholar
|
|
32.
|
Chen TM, Lin CC, Huang PT and Wen CF:
Neutrophil-tolymphocyte ratio associated with mortality in early
hepatocellular carcinoma patients after radiofrequency ablation. J
Gastroenterol Hepatol. 27:553–561. 2012. View Article : Google Scholar
|
|
33.
|
Chew V, Tow C, Teo M, et al: Inflammatory
tumour microenvironment is associated with superior survival in
hepatocellular carcinoma patients. J Hepatol. 52:370–379. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Coussens LM, Tinkle CL, Hanahan D and Werb
Z: MMP-9 supplied by bone marrow-derived cells contributes to skin
carcinogenesis. Cell. 103:481–490. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Strieter RM, Burdick MD, Mestas J,
Gomperts B, Keane MP and Belperio JA: Cancer CXC chemokine networks
and tumour angiogenesis. Eur J Cancer. 42:768–778. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Gong Y and Koh DR: Neutrophils promote
inflammatory angiogenesis via release of preformed VEGF in an in
vivo corneal model. Cell Tissue Res. 339:437–448. 2010. View Article : Google Scholar : PubMed/NCBI
|
